A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Cancer"
DOI: 10.1038/s41416-018-0281-9
Abstract: BackgroundWe conducted a phase I trial evaluating pembrolizumab+hypofractionated radiotherapy (HFRT) for patients with metastatic cancers.MethodsThere were two strata (12 patients each): (i) NSCLC/melanoma progressing on prior anti-PD-1 therapy, (ii) other cancer types; anti-PD-1-naive. Patients received… read more here.
Keywords: trial; patients metastatic; hypofractionated radiotherapy; pembrolizumab hypofractionated ... See more keywords